Allison Wheeler, Shrinath Kshirsagar, Adam Giermasz, Johnny Mahlangu, Gabriela Yamaguti-Hayakawa, Savita Rangarajan, Genevieve Moyer, Christine Kempton, Almudena Tercero, Paul Sims, Sandip Panicker, Chris Foo, Eileen Sawyer, Chris Del Nagro, Gary Patou, Benjamin Kim, Nicoletta Machin. "Subcutaneous, every-four-week maintenance dosing of a novel protein S antibody is well-tolerated and substantially reduces bleeding rates: Results from A phase 1/2 multidose study of VGA039 in patients with von Willebrand disease." Blood, 2025. doi:10.1182/blood-2025-308